NVS/NYSE - Novartis stock price & fundamentals

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide

Name	Novartis
Ticker	NVS
Exchange	NYSE
Sector	Health Care
Industry	Drug Manufacturers - Diversified

Price	86.46
52W Low/High	70.67 / 99.01
Market cap	196 B
1Y Total Return	2.10% Above Average
1Y Volatility	27.56% Low Risk

Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide

Details

Ticker	NVS
Name	Novartis
ISIN
CUSIP	66987V109
Exchange	NYSE
Sector	Health Care
Industry	Drug Manufacturers - Diversified
Country	Switzerland
Currency	U.S. Dollar

Share as of 6/2/20

Close Price	86.46
52W Low/High	70.67 / 99.01
Market cap	196 B
1Y Total Return	2.10% Above Average
1Y Volatility	27.56% Low Risk
Beta	0.31
PE (trailing)	17.09 Average
12M Dividends	13.452
Last Dividend Date	3/3/20
Dividend Yield	15.56%

Fin. Strength

Net Profit Margin	24.1%
Cash from Op. / Cur. Liabilities	0.48
Diluted Earnings / Share	5.06
ROE	17.5%
ROIC	13.8%
Price / Revenue	-
Price / Book	-
Price / CF	-
Current Ratio	1.0
Cur.Liabilities / Tot.Liabilities	0.4
Financial Leverage	0.53

in Mils USD	rolling-year up to December
Income Statement	2019	2018	2017	2016	2015	2014
Revenue	48,677 -8.4%	53,166 6.0%	50,135 1.4%	49,436 -1.9%	50,387 -6.1%	53,634 -
Gross Profit	34,252 -1.5%	34,759 5.5%	32,960 3.3%	31,916 -3.2%	32,983 -9.1%	36,289 -
R&D	9,402 3.6%	9,074 1.1%	8,972 -0.7%	9,039 1.2%	8,935 -1.7%	9,086 -
EBITDA	14,375 -2.8%	14,789 51.3%	9,776 14.5%	8,538 -56.3%	19,544 56.9%	12,459 -
Operating Income	7,055 8.9%	6,479 -2.7%	6,660 5.0%	6,341 -8.5%	6,928 -28.6%	9,698 -
Net Income exc. Extra	11,732 -7.0%	12,611 63.7%	7,703 14.8%	6,712 -62.3%	17,783 74.2%	10,210 -
per Share
Diluted avg Shares	- -	- -	- -	- -	- -	- -
EPS exc. Extra	5.06 -5.9%	5.38 65.5%	3.25 16.1%	2.80 -62.2%	7.40 75.8%	4.21 -
Dividend	13.45	2.21	2.33	2.76	2.39	2.72
Div. Yield (an.)	14.08%	2.58%	2.54%	3.83%	3.05%	2.75%
Balance Sheet	2019	2018	2017	2016	2015	2014
Total Assets	118,370 -18.7%	145,563 9.4%	133,079 2.3%	130,124 -1.1%	131,556 4.9%	125,387 -
Cash, Eq & Invt ShortTerm	11,446 -28.3%	15,964 68.3%	9,485 22.0%	7,777 42.8%	5,447 -60.7%	13,862 -
Total Current Assets	29,504 -17.0%	35,563 26.1%	28,208 13.1%	24,931 9.1%	22,845 -39.2%	37,561 -
Total Non-Current Assets	88,866 -19.2%	110,000 4.9%	104,871 -0.3%	105,193 -3.2%	108,711 23.8%	87,826 -
Intangibles	55,311 -25.3%	74,013 19.9%	61,747 -0.9%	62,320 -4.7%	65,391 23.0%	53,143 -
Total Liabilities	62,819 -6.1%	66,871 13.6%	58,852 6.6%	55,233 1.5%	54,434 -0.2%	54,543 -
Total Current Liabilities	28,264 -4.5%	29,607 26.5%	23,403 5.4%	22,209 -6.3%	23,708 -12.1%	26,973 -
Long Term Debt	34,555 -7.3%	37,264 5.1%	35,449 7.3%	33,024 7.5%	30,726 11.4%	27,570 -
Shareholder equity	55,474 -29.4%	78,614 6.0%	74,168 -0.9%	74,832 -2.9%	77,046 8.9%	70,766 -
Cash Flow	2019	2018	2017	2016	2015	2014
Cash from Operations	13,625 -4.5%	14,272 13.1%	12,621 10.0%	11,475 -3.5%	11,897 -14.4%	13,897 -
Depreciation	0 -	0 -	0 -	0 -	0 -	0 -
Cash from Investing	-2,226 60.2%	-5,591 -79.3%	-3,119 9.4%	-3,441 68.1%	-10,784 -1,324.1%	881 -
Capex	522 -68.8%	1,671 4.2%	1,604 -5.7%	1,701 -20.1%	2,130 -16.9%	2,564 -
Cash from Financing	-13,627 -221.1%	-4,244 45.1%	-7,733 -45.5%	-5,314 42.1%	-9,176 -12.6%	-8,147 -
Stock Issued	-5,332 -299.1%	-1,336 74.5%	-5,238 -485.3%	-895 80.1%	-4,490 0.6%	-4,515 -
Debt (LT) Issued	-4,957 -218.8%	4,171 4.5%	3,990 94.2%	2,055 4.8%	1,961 -40.9%	3,318 -
Free Cash Flow	11,541 -24.1%	15,213 202.4%	5,030 105.2%	2,451 -86.0%	17,552 72.8%	10,159 -
Ratios	2019	2018	2017	2016	2015	2014
Net Profit Margin	24.1%	23.7%	15.4%	13.6%	35.3%	19.0%
NCFO / Op.Income	193.1%	220.3%	189.5%	181.0%	171.7%	143.3%
Current Ratio	1.0	1.2	1.2	1.1	1.0	1.4
Financial Leverage D/E	0.53	0.41	0.38	0.32	0.28	0.29
Return on Capital Avg	13.8%	12.6%	8.1%	7.9%	18.8%	12.1%
Return on Shareholder Equity	17.5%	16.5%	10.3%	8.8%	24.1%	14.1%

Data

Google
Yahoo

Fundamentals

More Info